Correction: Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation

Correction: Evaluation of p16^INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation

Br J Cancer. 2021 Jul;125(2):307. doi: 10.1038/s41416-021-01457-z.

Steffen Wagner^#¹, Elena-Sophie Prigge^#^{2

3}, Nora Wuerdemann^{4

5}, Henrike Reder⁴, Ayman Bushnak⁴, Shachi Jenny Sharma^{4

5}, Theresa Obermueller^{2

3}, Magnus von Knebel Doeberitz^{2

3}, Thomas Dreyer⁶, Stefan Gattenlöhner⁶, Gregor Wolf⁴, Jörn Pons-Kühnemann⁷, Claus Wittekindt⁴, Jens Peter Klussmann^{4

5}

¹ Department of Otorhinolaryngology, Head and Neck Surgery, University of Giessen, Giessen, Germany. Steffen.Wagner@hno.med.uni-giessen.de.
² Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
³ Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴ Department of Otorhinolaryngology, Head and Neck Surgery, University of Giessen, Giessen, Germany.
⁵ Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.
⁶ Institute of Pathology, University of Giessen, Giessen, Germany.
⁷ Medical Statistics, Institute of Medical Informatics, University of Giessen, Giessen, Germany.

^# Contributed equally.

No abstract available